Generation Bio Q3 EPS $(0.43) Beats $(0.50) Estimate, Sales $2.15M Beat $1.09M Estimate
Portfolio Pulse from Benzinga Newsdesk
Generation Bio (NASDAQ:GBIO) reported Q3 losses of $(0.43) per share, beating the analyst consensus estimate of $(0.50) by 14 percent. This is an 18.87 percent increase over losses from the same period last year. The company also reported quarterly sales of $2.15 million, beating the analyst consensus estimate of $1.09 million by 96.88 percent.
November 09, 2023 | 11:40 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Generation Bio's Q3 results beat analyst estimates both in terms of EPS and sales. This could potentially have a positive impact on the company's stock.
Generation Bio reported better than expected Q3 results, with both EPS and sales beating analyst estimates. This positive financial performance could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100